Evaluation of antimicrobial activity of beta-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004)

Diagnostic Microbiology and Infectious Disease
Yoshikazu IshiiKeizo Yamaguchi

Abstract

This antimicrobial resistance surveillance study was performed in 100 medical centers. The susceptibility of 9347 strains including Escherichia coli (997 strains), Klebsiella spp. (997 strains), Enterobacter spp. (988 strains), Citrobacter spp. (834 strains), indole-positive Proteae spp. (855 strains), Serratia spp. (925 strains), Acinetobacter spp. (902 strains), Pseudomonas aeruginosa (996 strains), oxacillin-susceptible Staphylococcus aureus (992 strains), and coagulase-negative staphylococci (861 strains) to 7 beta-lactam antibiotics, cefepime, cefpirome, ceftazidime, cefoperazone/sulbactam, imipenem and piperacillin (for gram negatives), or oxacillin (for gram positives) was tested. No strain resistant to these beta-lactams except for ceftazidime was found in oxacillin-susceptible S. aureus and coagulase-negative staphylococci. E. coli (16.5%) clinical isolates were resistant to piperacillin, whereas 1.5% or less (cefpirome = 1.5%) was resistant to other beta-lactams. Klebsiella spp. strains were more susceptible to imipenem (99.7%), cefepime (98.4%), and cefpirome (97.3%). Isolates of Enterobacter spp., Citrobacter spp., indole-positive Proteae, and Serratia spp. were susceptible to imipenem, cefepime, and cefpirome, as w...Continue Reading

References

Jun 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Bolmström
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Soichiro KimuraKeizo Yamaguchi
Jan 28, 2005·The New England Journal of Medicine·George A Jacoby, Luisa Silvia Munoz-Price
Mar 24, 2005·International Journal of Antimicrobial Agents·Yoshikazu IshiiKeizo Yamaguchi
Apr 16, 2005·Clinical Microbiology Reviews·Timothy R WalshPatrice Nordmann
Sep 8, 2005·Journal of Clinical Microbiology·Sophie MarquéPatrice Nordmann
Sep 30, 2005·Journal of Medical Microbiology·Katsuaki ShirotoKeizo Yamaguchi

❮ Previous
Next ❯

Citations

Jan 20, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ErbH Brenner
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Hossein KhaliliAzita-Hajhosssein Talasaz
Feb 7, 2014·Pakistan Journal of Biological Sciences : PJBS·Nazar M AbdallaAbdalla M Al-Ghtani
Jun 17, 2010·Indian Journal of Pathology & Microbiology·Mohammad RahbarNegar Haji Aliakbari
Mar 15, 2011·Diagnostic Microbiology and Infectious Disease·Yoshikazu IshiiKeizo Yamaguchi
Oct 13, 2007·Diagnostic Microbiology and Infectious Disease·Yoshikazu IshiiUNKNOWN Japan Antimicrobial Resistance Surveillance Participants Group (JARS)
Jun 15, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jaffar A Al-Tawfiq, Thangiah X Mohandhas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.